LifeStance Health Group (LFST) to Release Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) will be posting its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect LifeStance Health Group to post earnings of ($0.09) per share for the quarter. LifeStance Health Group has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

LifeStance Health Group (NASDAQ:LFST) last issued its earnings results on Wednesday, February 28th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.03). LifeStance Health Group had a negative return on equity of 12.66% and a negative net margin of 17.64%. The company had revenue of $280.60 million during the quarter, compared to analyst estimates of $263.14 million. On average, analysts expect LifeStance Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $6.98 on Wednesday. LifeStance Health Group has a 1-year low of $4.74 and a 1-year high of $9.59. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.11 and a quick ratio of 1.11. The business’s fifty day moving average price is $6.45 and its two-hundred day moving average price is $6.54. The firm has a market capitalization of $2.67 billion, a PE ratio of -13.69 and a beta of 1.29.

Insider Activity

In other news, insider Kevin Michael Mullins sold 115,136 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $8.02, for a total transaction of $923,390.72. Following the transaction, the insider now directly owns 4,575,480 shares of the company’s stock, valued at $36,695,349.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Kevin Michael Mullins sold 115,136 shares of the firm’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $8.02, for a total transaction of $923,390.72. Following the completion of the transaction, the insider now owns 4,575,480 shares of the company’s stock, valued at $36,695,349.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Danish J. Qureshi sold 12,965 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $5.93, for a total value of $76,882.45. Following the transaction, the insider now directly owns 4,911,050 shares of the company’s stock, valued at approximately $29,122,526.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 245,463 shares of company stock valued at $1,786,868. Company insiders own 6.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $10.00 target price on shares of LifeStance Health Group in a research report on Monday, April 22nd. Jefferies Financial Group increased their target price on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Barclays increased their target price on LifeStance Health Group from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Thursday, February 29th. Finally, The Goldman Sachs Group raised their price target on LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $8.83.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.